Fused tricyclic compounds as inhibitors of tumor necrosis factor-alpha
Details for Australian Patent Application No. 2005303410 (hide)
International Classifications
Event Publications
24 May 2007 PCT application entered the National Phase
PCT publication WO2006/051477 Priority application(s): WO2006/051477
2 September 2010 Assignment before Grant
Nicholas Piramal India Limited The application has been assigned to Piramal Life Sciences Limited 2006
15 December 2011 Application Accepted
Published as AU-B-2005303410
12 April 2012 Standard Patent Sealed
1 November 2012 Assignment Registered
Piramal Life Sciences Limited The patent has been assigned to Piramal Enterprises Limited
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2005303409-Tricyclic guanidine derivatives as sodium-proton exchange inhibitors
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser